Navigation Links
ParagonRx Creates New Website Featuring REMS Help Center for Pharma
Date:7/13/2009

WILMINGTON, Del., July 13 /PRNewswire/ -- ParagonRx, a Delaware-based company which specializes in programs for the appropriate use of medications, has launched a new website - www.paragonrx.com - that includes a "REMS Hub" for pharmaceutical and biotech companies needing information and assistance in complying with new FDA requirements to ensure the medical benefits of a drug outweigh its risks and dangerous side effects.

"REMS, or Risk Evaluation and Mitigation Strategy, requires a whole new mindset for many professionals in the industry," according to ParagonRx CEO Jeffrey Fetterman, "in that patient safety is no longer merely a statistic that is passively measured for regulatory compliance. Now, patient safety is an objective that is actively managed by many functional groups and disciplines, including pharmacovigilance, marketing, medical, regulatory and legal. In many ways, risk management, including REMS, is becoming its own new discipline, and we believe that our online REMS Hub will be of great use to our colleagues in many disciplines.

"Our job is always to make our clients jobs easier," Fetterman continues. "The new website was specifically designed to make it simpler to share the new lessons being learned as we work through the evolving REMS processes. We all share an overwhelming desire to improve patient safety while ensuring the benefits of a pharmaceutical or biological solution can address a patient's health needs. Our goal is to use the website and Internet world to help build better communication and educational strategies reducing risks for physicians and patients."

The REMS Hub addresses the related but varying needs of pharma and bio companies working with risk management and REMS in any of a product's key stages - development, peri-approval, launch, and post-marketing. The Center also explains how a science-based approach to REMS development can assure both safer product use and often broader product use, as well.

(Note to media: Fetterman is available for interviews)


'/>"/>
SOURCE ParagonRx
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
2. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
3. MIT creates gecko-inspired bandage
4. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
5. CryoPort Creates Personal Wall on Wallst.nets Financial Social Community, my.wallst.net
6. Inclinix Expansion Creates New Position and Promotions
7. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
8. New process creates 3-D nanostructures with magnetic materials
9. MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position
10. Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says
11. GSK and Pfizer Innovative Agreement Creates Specialist HIV Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... ... June 14, 2017 , ... Slone Partners welcomed ... steered by the executive search firm, “Building Value in Precision Medicine: Can We ... of Foundation Medicine, led an open discussion with expert panelists Troy Cox, CEO ...
(Date:6/14/2017)... (PRWEB) , ... June 14, 2017 , ... The newest ... discover new therapeutic antibodies using rabbits that express human genes. ATGC, a spin out ... , Founded in 2015, ATGC is a translational genomics company. Its founders are ...
(Date:6/13/2017)... ... 2017 , ... Three newly formed companies have received $50,000 ... Recensa Therapeutics and Regennera, all P1V participants, will apply the funds to a ... a startup accelerator that helps launch and grow companies that have specific technology ...
(Date:6/13/2017)... ... 2017 , ... Presented at American Diabetes Association: Abstract #2017-LB-7091-Diabetes, ... to develop chronic kidney disease within four years , Study is the ... patients over a four year period , Results presented at the American ...
Breaking Biology Technology:
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):